BSAP can repress enhancer activity by targeting PU.1 function

Molecular and Cellular Biology

Volumn 20, Issue 6, 2000, Pages 1911-1922

  Maitra, Shanak ^a   Atchison, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE REPRESSION; LYMPHOCYTOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033998025     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.6.1911-1922.2000     Document Type: Article

References (74)

1. Adams, B., P. Dorfler, A. Aguzzi, Z. Kozmik, P. Urbanek, I. Mauer-Fogy, and M. Busslinger. 1992. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6:1589-1607.
2. Behre, G., A. J. Whitmarsh, M. P. Coghlan, T. Hoang, C. L. Carpenter, D.-E. Zhang, R. J. Davis, and D. G. Tenen. 1999. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J. Biol. Chem. 274:4939-4946.
3. Bushmeyer, S., K. Park, and M. L. Atchison. 1995. Characterization of functional domains within the multifunctional transcription factor, YY1. J. Biol. Chem. 270:30213-30220.
4. Busslinger, M., and S. L. Nutt (ed.). 1998. Role of the transcription factor BSAP (Pax-5) in B-cell development. Humana Press Inc., Totowa, N.J.
5. Celada, A., F. E. Borras, C. Soler, J. Lloberas, M. Klemsz, C. van Beveren, S. McKercher, and R. A. Maki. 1996. The transcription factor PU.1 is involved in macrophage proliferation. J. Exp. Med. 184:61-69.
6. Corcoran, A. E., A. Riddell, D. Krooshoop, and A. R. Venkitaraman. 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391:904-907.
7. Costa, M. W., and M. L. Atchison. 1996. Identification of an Sp1-like element within the immunoglobulin κ 3′ enhancer necessary for maximal enhancer activity. Biochemistry 35:8662-8669.
8. Czerny, T., G. Schaffner, and M. Busslinger. 1993. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev. 7:2048-2061.
9. DeKoter, R. P., J. C. Walsh, and H. Singh. 1998. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17:4456-4468.
10. De Monte, L., C. P. Thienes, S. Monticelli, M. Busslinger, H. J. Gould, and D. Vercelli. 1997. Regulation of human epsilon germline transcription: role of B-cell-specific activator protein. Int. Arch. Allergy Immunol. 113:35-38.
11. Dorfler, P., and M. Busslinger. 1996. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J. 15:1971-1982.
12. Eberhard, D., and M. Busslinger. 1999. The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins. Cancer Res. 59:1716S-1725S.
13. Feldhaus, A. L., D. Mbangkollo, K. L. Arvin, C. A. Klug, and H. Singh. 1992. BLyF, a novel cell-type and stage-specilic regulator of the B-lymphocyte gene mb-1. Mol. Cell. Biol. 12:1126-1133.
14. Fisher, R. C., M. C. Olson, J. M. R. Pongubala, J. M. Perkel, M. L. Atchison, E. W. Scott, and M. C. Simon. 1998. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain. Mol. Cell. Biol. 18:4347-4357.
15. Fitzsimmons, D., W. Hodsdon, W. Wheat, S.-M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198-2211.
16. Glimcher, L. H., and H. Singh. 1999. Transcription factors in lymphocyte development - T and B cells get together. Cell 96:13-23.
17. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
18. Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
19. Hagman, J., A. Travis, and R. Grosschedl. 1991. A novel lineage-specific nuclear factor regulates mb-1 gene transcription at early stages of B cell differentiation. EMBO J. 10:3409-3417.
20. Hayashi, R., T. Takemori, M. Kodama, M. Suzuki, A. Tsuboi, F. Nagawa, and H. Sakano. 1997. The PU.1 binding site is a cis-element that regulates pro-B/pre-B specificity of Vκ-Jκ joining. J. Immunol. 159:4145-4149.
21. Henkel, G. W., S. R. McKercher, P. J. Leenen, and R. A. Maki. 1999. Commitment to the monocytic lineage occurs in the absence of the transcription factor PU.1. Blood 93:2849-2858.
22. Hiramatsu, R., K. Akagi, M. Matsuoka, K. Sakumi, H. Nakamura, L. Kingsbury, C. David, R. R. Hardy, K.-i. Yamamura, and H. Sakano. 1995. The 3′ enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin Vκ-Jκ joining. Cell 83:1113-1123.
23. Judde, J.-G., and E. E. Max. 1992. Characterization of the human immunoglobulin kappa gene 3′ enhancer: functional importance of three motifs that demonstrate B-cell-specitic in vivo footprints. Mol. Cell. Biol. 12:5206-5216.
24. Klemsz, M. J., and R. A. Maki. 1996. Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol. Cell. Biol. 16:390-397.
25. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the Ets oncogene. Cell 61:113-124.
26. Kozmik, Z., S. Wang, P. Dorfler, B. Adams, and M. Busslinger. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662-2672.
27. Lauring, J., and M. S. Schlissel. 1999. Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines. Mol. Cell. Biol. 19:2601-2612.
28. Liao, F., B. K. Birshtein, M. Busslinger, and P. Rothman. 1994. The transcription factor BSAP (NF-HB) is essential for immunoglobulin germ-line epsilon transcription. J. Immunol. 152:2904-2911.
29. Libermann, T. A., Z. Pan, Y. Akbarali, C. J. Hetherington, J. Boltax, D. A. Yergeau, and D. E. Zhang. 1999. AML (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J. Biol. Chem. 274:24671-24676.
30. McKercher, S. R., B. E. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, and R. A. Maki. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:5647-5658.
31. Meyer, K. B., and J. Ireland. 1994. Activation of the immunoglobulin κ 3′ enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core. Nucleic Acids Res. 22:1576-1582.
32. Meyer, K. B., and M. S. Neuberger. 1989. The immunoglobulin κ locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 8:1959-1964.
33. Michaelson, J. S., M. Singh, C. M. Snapper, W. C. Sha, D. Baltimore, and B. K. Birshtein. 1996. Regulation of the 3′ IgH enhancers by a common set of factors including κB-binding proteins. J. Immunol. 156:2828-2839.
34. Moreau-Gachelin, F., D. Ray, M.-G. Mattei, P. Tambourin, and A. Tavitian. 1989. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene 4:1449-1456.
35. Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature 331:277-280.
36. Moreau-Gachelin, F., F. Wendling, T. Monina, N. Denis, M. Titeux, G. Grimber, P. Briand, W. Vainchenker, and A. Tavitian. 1996. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell. Biol. 16: 2453-2463.
37. Morrison, A. M., S. L. Nutt, C. Thevenin, A. Rolink, and M. Busslinger. 1998. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation. Semin. Immunol. 10:133-142.
38. Nerlov, C., and T. Graf. 1998. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:2403-2412.
39. Neurath, M. F., E. E. Max, and W. Strober. 1995. Pax5 (BSAP) regulates the murine immunoglobulin 3′α enhancer by suppressing binding of NF-αP, a protein that controls heavy chain transcription. Proc. Natl. Acad. Sci. USA 92:5336-5340.
40. Neurath, M. F., W. Strober, and Y. Wakatsuki. 1994. The murine 1g 3′α enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, Sα-BP). J. Immunol. 153:730-742.
41. Nutt, S. L., B. Heavey, A. G. Rolink, and M. Busslinger. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-562.
42. Nutt, S. L., A. M. Morrison, P. Dorfler, A. Rolink, and M. Busslinger. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss-and gain-of-function experiments. EMBO J 17:2319-2333.
43. Nutt, S. L., C. Thevenin, and M. Busslinger. 1997. Essential functions of Pax-5 (BSAP) in pro-B cell development. Immunobiology 198:227-235.
44. Olson, M. C., E. W. Scott, A. A. Hack, G. H. Su, D. G. Tenen, H. Singh, and M. C. Simon. 1995. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3:703-714.
45. Park, K., and M. L. Atchison. 1991. Isolation of a candidate repressor/ activator, NF-E1 (YY-1, δ), that binds to the immunoglobulin κ 3′ enhancer and the immunoglobulin heavy-chain μE1 site. Proc. Natl. Acad. Sci. USA 88:9804-9808.
46. Paul, R., S. Schuetz, S. L. Kozak, C. A. Kozak, and D. Kabat. 1991. The Sfpi-1 proviral integration site of Friend erythroleukemia virus encodes the ets-related transcription factor PU.1. J. Virol. 65:464-467.
47. Perkel, J. M., and M. L. Atchison. 1998. A two-step mechanism for recruitment of Pip by PU.1. J. Immunol. 160:241-252.
48. Pongubala, J. M. R., and M. L. Atchison. 1995. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin κ 3′ enhancer. J. Biol. Chem. 270:10304-10313.
49. Pongubala, J. M. R., and M. L. Atchison. 1991. Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-lielix transcription factors. Mol. Cell. Biol. 11:1040-1047.
50. Pongubala, J. M. R., and M. L. Atchison. 1997. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc. Nail. Acad. Sci. USA 94:127-132.
51. Pongubala, J. M. R., S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1992. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell. Biol. 12:368-378.
52. Pongubala, J. M. R., C. Van Beveren, S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1993. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622-1625.
53. Reimold, A. M., P. D. Ponath, Y. S. Li, R. R. Hardy, C. S. David, J. L. Strominger, and L. H. Glimcher. 1996. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183:393-401.
54. Rekhtman, N., R. Radparvar, T. Evans, and A. I. Skoultchi, 1999. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 13:1398-1411.
55. Rinkenberger, J. L., J. J. Wallin, K. W. Johnson, and M. E. Koshland. 1993. An interleukin-2 signal relieves BSAP (PAX-5)-mediated repression of the immunoglobulin J chain gene. Immunity 5:377-386.
56. Roque, M. C., P. A. Smith, and V. C. Blazquez. 1996. A developmentally modulated chromatin structure at the mouse immunoglobulin κ 3′ enhancer. Mol. Cell. Biol. 16:3138-3155.
57. Schuetze, S., P. E. Sternberg, and D. Kabat. 1993. The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell. Biol. 13:5670-5678.
58. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-1577.
59. Shaffer, A. L., A. Peng, and M. S. Schlissel. 1997. In vivo occupancy of the κ light chain enhancers in primary pro- and pre-B cells: a model for κ locus activation. Immunity 6:131-143.
60. Singh, H., R. P. DeKoter, and J. C. Walsh. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harbor Symp. Quant. Biol., in press.
61. Singh, M., and B. K. Birshtein. 1993. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ α enhancer at early stages of B-cell differentiation. Mol. Cell. Biol. 13:3611-3622.
62. Tell, G., A. Scaloni, L. Pellizzari, S. Formisano, C. Pucillo, and G. Damante. 1998. Redox potential controls the structure and DNA binding activity of the paired domain. J. Biol. Chem. 273:25062-25072.
63. Theines, C. P., L. De Monte, S. Monticelli, M. Busslinger, H. J. Gould, and D. Vercelli. 1997. The transcription factor B cell-specific activator protein (BSAP) enhances both 1L-4- and CD40-mediated activation of the human epsilon germline promoter. J. Immunol. 158:5874-5882.
64. Travis, A., J. Hagman, and R. Grosschedl. 1991. Heterogeneously initiated transcription from the pre-B-and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor binding sites and initiation site sequences. Mol. Cell. Biol. 11:5756-5766.
65. Urbanek, P., Z. Q. Wang, I. Fetka, E. F. Wagner, and M. Busslinger. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking pax 5/BSAP. Cell 79:901-912.
66. Voso, M. T., T. C. Burn, G. Wulf, B. Lim, G. Leone, and D. G. Tenen. 1994 Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc. Natl. Acad. Sci. USA 91:7932-7936.
67. Wallin, J. J., E. R. Gackstetter, and M. E. Koshland. 1998. Dependence of BSAP repressor and activator functions on BSAP concentration. Science 279:1961-1964.
68. Wakatsuki, Y. W., M. F. Neurath, E. E. Max, and W. Strober. 1994. The B-cell specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 179:1099-1108.
69. Wheat, W., D. Fitzsimmons, H. Lennox, S. R. Krautkramer, L. N. Gentile, L. P. McIntosh, and J. Hagman. 1999. The highly conserved β-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes. Mol. Cell. Biol. 19:2231-2241.
70. Yamamoto, H., F. Kihara-Negishi, T. Yamada, Y. Hashimoto, and T. Oikawa. 1999. Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP. Oncogene 18:1495-1501.
71. Ying, H., J. I. Healy, C. C. Goodnow, and J. R. Parnes. 1998. Regulation of mouse CD72 gene expression during B lymphocyte development. J. Immunol. 161:4760-4767.
72. Zhang, P., G. Behre, J. Pan, A. Iwama, N. Wara-Aswapati, H. S. Radomska, P. E. Auron, D. G. Tenen, and Z. Sun. 1999. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc. Natl. Acad. Sci. USA 96:8705-8710.
73. Zwollo, P., and S. Desiderio. 1994. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell specific activator protein. J. Biol. Chem. 269:15310-15317.
74. Zwollo, P., S. Rao, J. J. Wallin, E. R. Gackstetter, and M. E. Koshland. 1998. The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation. J. Biol. Chem. 273:18647-18655.